Biohaven Pharmaceutical (BHVN) had the highest return in October 2022 by a US stock with a market cap of $2B+, returning 159.3%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Biohaven Pharmaceutical (BHVN) | October 2022 | 159.31% |
Advantage Solutions (ADVWW) | October 2022 | 129.77% |
Immunovant (IMVT) | October 2022 | 97.53% |
Nuvalent (NUVL) | October 2022 | 82.57% |
Vaxcyte (PCVX) | October 2022 | 78% |
Oceaneering International (OII) | October 2022 | 66.15% |
Roivant Sciences (ROIV) | October 2022 | 61.64% |
Avis Budget (CAR) | October 2022 | 54.34% |
QXO (QXO) | October 2022 | 50.69% |
Tidewater (TDW) | October 2022 | 50.67% |
Viking Therapeutics (VKTX) | October 2022 | 48.55% |
DexCom (DXCM) | October 2022 | 48.25% |
Norwegian Cruise Line (NCLH) | October 2022 | 46.23% |
Vertiv (VRT) | October 2022 | 44.11% |
Impinj (PI) | October 2022 | 42.95% |
Seadrill (SDRL) | October 2022 | 42.53% |
Patterson-UTI Energy (PTEN) | October 2022 | 42.13% |
Sylvamo (SLVM) | October 2022 | 41.63% |
Transocean (RIG) | October 2022 | 41.54% |
Enerpac Tool (EPAC) | October 2022 | 40.89% |
Medpace (MEDP) | October 2022 | 40.68% |
Halliburton (HAL) | October 2022 | 40.13% |
ChampionX (CHX) | October 2022 | 39.68% |
Royal Caribbean Cruises (RCL) | October 2022 | 38.9% |
Schlumberger (SLB) | October 2022 | 38.45% |
